Back
Kforce, Inc. 10K Form
Buy
53
KFRC
Kforce, Inc.
Last Price:
$36.97
Seasonality Move:
4.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | KFRC/Kforce, Inc. Quarterly |
| 2023-11-01 | 10Q | KFRC/Kforce, Inc. Quarterly |
| 2023-08-02 | 10Q | KFRC/Kforce, Inc. Quarterly |
| 2023-05-09 | 10Q | KFRC/Kforce, Inc. Quarterly |
| 2022-11-02 | 10Q | KFRC/Kforce, Inc. Quarterly |
| 2022-08-03 | 10Q | KFRC/Kforce, Inc. Quarterly |
Receive KFRC News And Ratings
See the #1 stock for the next 7 days that we like better than KFRC
KFRC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $19.8M |
| Price / Cash Flow: | 12.64 |
| Annual Sales: | $7.22 |
| Price / Book: | 5.02 |
Profitability
| EPS (TTM): | 1.95880 |
|---|---|
| Net Income (TTM): | $34.8M |
| Gross Margin: | $355.8M |
| Return on Equity: | 25.47% |
| Return on Assets: | 9.41% |
Kforce, Inc. Earnings Forecast
Key Kforce, Inc. Financial Ratios
-
The Gross Profit Margin over the past 32 years for KFRC is 26.77%.
-
The Selling, General & Administrative Expenses for KFRC have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of KFRC is 2.62% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 19 years.
Kforce, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Professional Services |
| Sector: | Industrials |
| Current Symbol: | KFRC |
| CUSIP: | 493732 |
| Website: | kforce.com |
Debt
| Debt-to-Equity Ratio: | 0.56 |
|---|---|
| Current Ratio: | 1.78 |
| Quick Ratio: | 1.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.65 |
|---|---|
| Forward P/E Ratio: | 13.37 |
KFRC Technical Analysis vs Fundamental Analysis
Buy
53
Kforce, Inc. (KFRC)
is a Buy
Is Kforce, Inc. a Buy or a Sell?
-
Kforce, Inc. stock is rated a BuyThe current Kforce, Inc. [KFRC] share price is $36.53. The Score for KFRC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.